Historical Stock Price
ETFs Holding ABT »    ABT Split History »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
11/30/2018 $73.93 $74.23 $73.07 $74.05 8.03M
12/03/2018 $74.29 $74.92 $73.56 $74.27 6.43M
12/04/2018 $74.24 $74.25 $71.43 $71.50 7.62M
12/06/2018 $70.59 $71.54 $69.92 $71.54 10.27M
12/07/2018 $71.75 $71.83 $69.19 $69.95 7.83M
Abbott Laboratories is engaged in the discovery, development, manufacture, and sale of a line of health care products. Co. has four reportable segments: Established Pharmaceutical Products, which sells a line of branded generic pharmaceutical products internationally; Nutritional Products, which sells adult and pediatric nutritional products; Diagnostic Products, which sells diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites; and Cardiovascular and Neuromodulation Products, which include rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases.
ABT historical stock prices picture
Abbott Laboratories (ABT) has the following price history information. Looking back at ABT historical stock prices for the last five trading days, on November 30, 2018, ABT opened at $73.93, traded as high as $74.23 and as low as $73.07, and closed at $74.05. Trading volume was a total of 8.03M shares. On December 03, 2018, ABT opened at $74.29, traded as high as $74.92 and as low as $73.56, and closed at $74.27. Trading volume was a total of 6.43M shares. On December 04, 2018, ABT opened at $74.24, traded as high as $74.25 and as low as $71.43, and closed at $71.50. Trading volume was a total of 7.62M shares. On December 06, 2018, ABT opened at $70.59, traded as high as $71.54 and as low as $69.92, and closed at $71.54. Trading volume was a total of 10.27M shares. On December 07, 2018, ABT opened at $71.75, traded as high as $71.83 and as low as $69.19, and closed at $69.95. Trading volume was a total of 7.83M shares.

ABT Historical Stock Prices By Date:

ABT historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Abbott Laboratories shares, starting with a $10,000 purchase of ABT, and working forward through the historical stock price information to today.

Growth of $10,000.00
With Dividends Reinvested

Start date: 12/09/2008
End date: 12/07/2018
Start price/share: $24.94
End price/share: $69.95
Starting shares: 400.96
Ending shares: 519.98
Dividends reinvested/share: $9.06
Total return: 263.73%
Average Annual Total Return: 13.78%
Starting investment: $10,000.00
Ending investment: $36,362.97
Years: 10.00
 
Growth of $10,000.00
Without Dividends Reinvested

Start date: 12/09/2008
End date: 12/07/2018
Start price/share: $24.94
End price/share: $69.95
Dividends collected/share: $9.06
Total return: 216.80%
Average Annual Total Return: 12.22%
Starting investment: $10,000.00
Ending investment: $31,673.98
Years: 10.00
Date Close
11/30/2018$74.05
12/03/2018$74.27
12/04/2018$71.50
12/06/2018$71.54
12/07/2018$69.95
ABT is categorized under the Healthcare sector; below are some other companies in the same sector:

ABV Historical Stock Prices
ACAD Historical Stock Prices
ACER Historical Stock Prices
ACET Historical Stock Prices
ACHC Historical Stock Prices
ACHN Historical Stock Prices
ACHV Historical Stock Prices
ACOR Historical Stock Prices
ACRS Historical Stock Prices
ACRX Historical Stock Prices

Also explore: ABT shares outstanding history

ABT Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2018, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.